Dashboard Tools Market News Investing Ideas Pricing
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
G

Galderma Group AG
SIX:GALD

Watchlist Manager
Galderma Group AG
SIX:GALD
Watchlist
Price: 155 CHF 0.85% Market Closed
Market Cap: CHf36.8B
Write Note Create Alert Ask AI

Wall St Price Targets

GALD Price Targets Summary
Galderma Group AG

Wall Street analysts forecast GALD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GALD is 201.75 CHF with a low forecast of 152.26 CHF and a high forecast of 273 CHF.

GALD Lowest Forecast
Wall Street Target
CHf152.26
-2% Downside
GALD Average Forecast
Wall Street Target
CHf201.75
30% Upside
GALD Highest Forecast
Wall Street Target
CHf273
76% Upside
Lowest Forecast
Price Target
152.26 CHF
2% Downside
Average Forecast
Price Target
201.75 CHF
30% Upside
Highest Forecast
Price Target
273 CHF
76% Upside
Galderma Group AG Competitors:
Price Targets
CAG
Conagra Brands Inc
-1% Downside
CAG
Conagra Brands Inc
-1% Downside

Revenue
Forecast

11% / Year
Past Growth
13% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
11% / Year
Past Growth
13% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 13%.

What are analyst estimates?

Gross Profit
Forecast

11% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
11% / Year
Past Growth
15% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 8 years is 15%.

What are analyst estimates?

Operating Income
Forecast

30% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
30% / Year
Past Growth
20% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 3 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 8 years is 20%.

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
57% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
57% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Pre-Tax Income over the next 3 years is 57%.

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
28% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
28% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Net Income over the next 8 years is 28%.

What are analyst estimates?

Continue GALD Research

Summary
GALD intrinsic value, competitors valuation, and company profile.
DCF Valuation
GALD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GALD stock valuation using valuation multiples.
Wall St Estimates
GALD price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GALD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Galderma Group AG listings:
OTC • USD
GDERF
 OTC • USD
GALDY
 F • EUR
PY30
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is GALD's stock price target?
Price Target
201.75 CHF

According to Wall Street analysts, the average 1-year price target for GALD is 201.75 CHF with a low forecast of 152.26 CHF and a high forecast of 273 CHF.

What is the Revenue forecast for Galderma Group AG?
Projected CAGR
13%

Over the last 3 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 8 years is 13%.

What is the Gross Profit forecast for Galderma Group AG?
Projected CAGR
15%

Over the last 3 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 8 years is 15%.

What is the Operating Income forecast for Galderma Group AG?
Projected CAGR
20%

Over the last 3 years, the compound annual growth rate for Operating Income has been 30%. The projected CAGR for the next 8 years is 20%.

What is the Pre-Tax Income forecast for Galderma Group AG?
Projected CAGR
57%

The compound annual growth rate for Pre-Tax Income over the next 3 years is 57%.

What is the Net Income forecast for Galderma Group AG?
Projected CAGR
28%

The compound annual growth rate for Net Income over the next 8 years is 28%.

Back to Top
ALPHA SPREAD
Follow us
Join 357,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

AI Assistant
Get AI-powered insights for any company or topic.
Open AI Assistant
Other Tools
Stock Screener
Discover stocks
Stock Comparison
Smarter decisions through side-by-side analysis
Intrinsic Value Calculator
Discover the true worth of your stocks
DCF Value Calculator
Harness the power of DCF

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett